Investigation of the metabolic stability of olmutinib by validated LC-MS/MS: quantification in human plasma
Keyword(s):
Olmutinib (OTB, Olita™) is an orally available third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI).
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915
2003 ◽
Vol 94
(5)
◽
pp. 453-458
◽
2021 ◽
2014 ◽
Vol 21
(S4)
◽
pp. 610-618
◽
2015 ◽
Vol 16
(6)
◽
pp. e259-e261
◽
2008 ◽
Vol 99
(8)
◽
pp. 1611-1617
◽
2003 ◽
Vol 30
(3)
◽
pp. 261-262
◽